Please join us for a review of the Barrigel Pivotal Data, published in @JAMAOnc! Principal Investigators in the trial, Drs. Martin King, @neilfmar, and @peter_orio will discuss this multinational randomized controlled clinical trial. https://t.co/kTMkUSRIsL #UroSoMe#RadOnc
Now published in @JAMAOnc! #Barrigel is proven safe and effective at achieving a clinically significant reduction in radiation dose to the rectum, leading to fewer side effects. Read the press release: https://t.co/orwbulyDe2 #Pcsm#RadOnc@peter_orio@MtkingMD
Just released Statement: ASTRO deeply disappointed in RO cuts & fears for stability of community-based cancer clinics. LINK: https://t.co/aThAPhuOIs
@DrChowdharyMD @ASTRO_org@AmericanBrachy A problem indeed. CPT code reimbursements factor in physician work, practice expense and malpractice risk. This is universal for all specialities and codes in our current rate setting system. This means a less effective therapy may actually pay more. Misaligned incentives!
Patient Safety Week is upon us: For patient safety in brachytherapy, communication among team members and a focus on continuous improvement and are essential. Deufel and colleagues recently showed that an incident learning system reduced risk during from brachytherapy procedures
To all my friends who do Brachytherapy please do the following practice of pattern survey and help us understand current practice of treating endometrial cancer #GynCsm https://t.co/oI4Ku4i1Y6
Was honored to present the agenda for the @AmerBrachy 2019 annual meeting to the ABS Board yesterday. I appreciate their support as we build an exciting program to generate awareness for patients and practitioners. #brachytherapy is an essential tool in the war against cancer